| 3,811 | 31 | 225 |
| 下载次数 | 被引频次 | 阅读次数 |
痤疮是毛皮脂腺单位的慢性疾病，表现为炎症性或非炎症性病变，主要影响面部，但也影响背部和胸部。目前还未彻底地研究清楚痤疮的发病机制，现有资料表明，痤疮的发病因素很多，包括遗传因素、皮脂过度分泌、毛囊皮脂腺导管异常角化、痤疮丙酸杆菌大量繁殖、炎症和免疫反应等。痤疮常用的治疗方法有局部外用药物治疗、系统药物治疗、光电治疗、化学剥脱治疗、微针治疗等。本文就痤疮的治疗研究进展进行综述。
Abstract：Acne is a chronic disease of the sebaceous gland unit, presenting as inflammatory or non-inflammatory changes that mainly affect the face, and also the back and chest. At present, the pathogenesis of acne has not been thoroughly studied.Current data indicate that there are many pathogenesis factors of acne, including genetic factors,excessive sebum secretion, abnormal keratosis of sebaceous ducts in hair follicles, massive multiplication of propionibacterium acne, inflammation and immune reaction, etc. The commonly used treatment methods for acne are topical drug therapy, systematic drug therapy, photoelectric therapy,chemical stripping therapy,microneedle therapy, etc. This article reviewsthe research progress in thetreatment of acne.
[1] KAROGLAN A, GOLLNICK H P M. Akne[J]. Hautarzt, 2021,72(9):815-827.
[2]张楠雪，卢忠，马英.痤疮的抗生素治疗及耐药现状[J].中国麻风皮肤病杂志，2018,34(1):61-64.
[3] KOLLI S S, PECONE D, PONA A,et al. Topical retinoids in acne vulgaris:a systematic review[J]. Am J Clin Dermatol, 2019,20(3):345-365.
[4] CALLENDER V D, BALDWIN H, COOK-BOLDEN F E, et al. Effects of Topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color:a clinical review and implications for practice[J].Am J Clin Dermatol, 2022,23(1):69-81.
[5]李文锐，林麟.外用维A酸治疗皮肤病的进展[J].国际皮肤性病学杂志，2017,43(3):133-136.
[6] KHALIL S, BARDAWIL T, STEPHAN C, et al. Retinoids:a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects[J]. J Dermatolog Treat, 2017,28(8):684-696.
[7] YANG ZR, ZHANG Y, LAZIC MOSLER E, et al. Topical benzoyl peroxide for acne[J]. Cochrane Database Syst Rev, 2020,3(3):CD011154.
[8] BOONCHAYA P, ROJHIRUNSAKOOL S, KAMANAMOOL N, et al. Minimum contact time of 1. 25%,2. 5%, 5%, and 10%benzoyl peroxide for a bactericidal effect against cutibacterium acnes[J]. Clin CosmetInvestig Dermatol, 2022,15:403-409.
[9] AYATOLLAHI A, SAMADI A, BAHMANJAHROMI A,et al. Efficacy and safety of topical spironolactone 5%cream in the treatment of acne:a pilot study[J]. Health Sci Rep, 2021,4(3):e317.
[10] NOAIMI A, AL-SAADI S R. Treatment of acne vulgaris by topical spironolactone solution compared with clindamycin solution[J]. Cureus, 2021,13(8):e17606.
[11] KAUL G, SAXENA D, DASGUPTA A, et al. Sarecycline hydrochloride for the treatment of acne vulgaris[J]. Drugs Today, 2019,55(10):615-625.
[12] VALENTE DUARTE DE SOUSA I C. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris[J]. Expert Opin Pharmacother, 2021,22(2):145-154.
[13] SADEGHZADEH-BAZARGAN A, GHASSEMI M,GOODARZI A, et al. Systematic review of low-dose isotretinoin for treatment of acne vulgaris:focus on indication,dosage,regimen,efficacy,safety,satisfaction,and follow up,based on clinical studies[J]. Dermatol Ther, 2021,34(1):e14438.
[14] BAGATIN E, COSTA C S. The use of isotretinoin for acne-an update on optimaldosing, surveillance, and adverse effects[J]. Expert Rev Clin Pharmacol, 2020,13(8):885-897.
[15]夏晓雪，缪旭，张冬梅，等.维甲酸类药物的临床应用及对生殖的影响[J].皮肤病与性病，2020,42(4):498-501.
[16] BETTOLI V, GUERRA-TAPIA A, HERANE M I, et al. Challenges and solutions in oral isotretinoin in acne:reflections on 35 years of experience[J]. Clin CosmetInvestig Dermatol, 2019,12:943-951.
[17]许秀宽，陈艺宏，张洪辉，等.小剂量激素联合米诺环素治疗重度痤疮临床疗效观察[J].福建医药杂志，2021,43(1):26-28.
[18] WALOCKO F M, EBER A E, KERI J E, et al. The role of nicotinamide in acne treatment[J]. Dermatol Ther, 2017,30(5):e12481.
[19] SEARLE T, AL-NIAIMI F, ALI F R. Dapsone for acne:still in use after half a century[J]. J Cosmet Dermatol, 2021,20(7):2036-2039.
[20] YEE B E, RICHARDS P, SUI J Y, et al. Serum zinc levels and efficacy of zinc treatment in acne vulgaris:a systematic review and meta-analysis[J]. Dermatol Ther, 2020,33(6):e14252.
[21]邓仁远，曹煜，张桂芝.痤疮的治疗进展[J].临床医药文献电子杂志，2018,5(88):197-198.
[22] PERPER M, TSATALIS J, EBER A E, et al. Lasers in the treatment of acne[J]. G Ital Dermatol Venereol,2017,152(4):360-372.
[23] CHALERMSUWIWATTANAKAN N, ROJHIRUNSAKOOL S, KAMANAMOOL N, et al. The comparative study of efficacy between 1064-nm long-pulsed Nd:YAG laser and 595-nm pulsed dye laser for the treatment of acne vulgaris[J]. J Cosmet Dermatol, 2021,20(7):2108-2115.
[24]杜霞，王思平. 5-氨基酮戊酸光动力治疗中重度痤疮的疗效观察及护理[J].中国医药指南，2017,15(7):15-16.
[25]许峥，曹蕾.果酸治疗轻中度寻常性痤疮临床疗效分析[J].中国美容医学，2017,26(10):79-81.
[26]王娟，龚海波.果酸联合盐酸米诺环素治疗寻常性痤疮疗效观察[J].中国美容医学，2017,26(8):103-104.
[27]夏栩琼，徐慧，陆雯丽，等. 30%超分子水杨酸治疗寻常痤疮的疗效观察[J]．中国皮肤性病学杂志，2019,33(5):616-619.
[28]李小英.外涂20%超分子水杨酸及口服盐酸米诺环素联合红蓝光治疗中重度痤疮51例[J].安徽医药，2021,25(2):366-369.
[29] SITOHANG I B S, SIRAIT S A P, SURYANEGARA J.Microneedling in the treatment of atrophic scars:a systematic review of randomised controlled trials[J]. Int Wound J, 2021,18(5):577-585.
[30] VILLANI A, CARMELA ANNUNZIATA M, ANTONIETTA LUCIANO M, et al. Skin needling for the treatment of acne scarring:a comprehensive review[J]. J Cosmet Dermatol, 2020,19(9):2174-2181.
[31] LI C X, YOU Z X, LIN Y X, et al. Skin microbiome differences relate to the grade of acne vulgaris[J]. J Dermatol, 2019,46(9):787-790.
[32] DRéNO B, DAGNELIE M A, KHAMMARI A, et al.The skin microbiome:a new actor in inflammatory acne[J]. Am J Clin Dermatol, 2020,21(Suppl 1):18-24.
[33] ROBINSON S, KWAN Z, TANG M M. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris:a randomized open-labeled study[J]. Dermatol Ther, 2019,32(4):e12953.
[34] JANUáRIO A P, FéLIX R, FéLIX C, et al. Red seaweed-derived compounds as a potential new approach for acne vulgaris care[J]. Pharmaceutics, 2021,13(11):1930.
[35] CASTILLO D E, NANDA S, KERI J E. Propionibacterium(Cutibacterium)acnes bacteriophage therapy in acne:current evidence and future perspectives[J]. Dermatol Ther, 2019,9(1):19-31.
基本信息:
中图分类号:R758.733
引用信息:
[1]吴炜,李燕,曾招林.痤疮的治疗研究进展[J].赣南医学院学报,2022,42(12):1323-1329.
2022-06-11
2022
2022-10-14
2022
1
2022-12-28
2022-12-28